Publications Old

Choose from a variety of resources to get a better understanding of Syngene’s point of view, expertise or approach to drug discovery, development and manufacturing to ensure client success.

Targeted Protein Degradation and Novel Modalities: Getting on the Frontline
Publication: Fierce Pharma
9th May, 2026
Electrochemical Synthesis of Self-immolative Methylene Alkoxy Carbamate (MAC) to Facilitate Construction of Antibody–drug Conjugate Linkers with Alcohol-containing Payloads
Publication: Thieme
29th Apr, 2026
Direct to Biology for Drug Discovery Acceleration: Syngene’s D2B Platform
Publication: Pharmaceutical Technology Focus
13th Apr, 2026
Peptides in the pipeline: How companies are overcoming the early-stage challenges
Publication: Pharmaceutical Technology Focus
7th Mar, 2026
Intraperitoneal Injection of Sesame Oil as Vehicle Induces Decidual Reaction in Female Rats: A Review of In-House Data
Publication: Sage Journal
28th Dec, 2025
Bile acid modulators in discovery: Identifying cholestasis candidates with the best chance of success
Publication: Pharmaceutical Technology Focus
8th Jan, 2026
GLP-1 Drugs Now Stand at the Centre of a Multi-Disease Treatment Revolution
Publication: Pharmaceutical Technology Focus
1st Jan, 2026
Integrated Innovation Partners: The Strategic Edge in Modern Drug Development
Publication: Pharmaceutical Technology Focus
29th Oct, 2025
Development of a Scalable Process for the Synthesis of Cyclopropyl-Methyl-Proline with Complex Stereochemistry: A Key Building Block of Factor D Inhibitors
Publication: ACS Publications
20th Oct, 2024
BWC0977, a broad-spectrum antibacterial clinical candidate to treat multidrug resistant infections
Publication: Nature Communications
15th Sep, 2024